报价延迟最少15分钟:2025/09/16 23:15 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
3.22 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.68/0.24
|
|
企业价值
248.67M
|
| 资产负债 |
|
每股账面净值
5.21
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
405.47M
|
|
每股收益
6.19
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/09/16 23:15 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States. |
